Citation Impact
Citing Papers
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
To Interfere and to Anti-interfere: The Interplay Between Hepatitis C Virus and Interferon
2002
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Hepatocellular carcinoma
2003 Standout
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Circulating mitochondrial DAMPs cause inflammatory responses to injury
2010 StandoutNature
Testosterone Therapy For Human Immunodeficiency Virus-Positive Men With and Without Hypogonadism
1999
Limitations of non-invasive tests for assessment of liver fibrosis
2020
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Inflammation and metabolic disorders
2006 StandoutNature
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Liver fibrosis
2005 Standout
Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis
2017
Impact of obesity on treatment of chronic hepatitis C†
2006
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
2003 Standout
Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
2016 StandoutNobel
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Sex Hormone Dependency of Diethylnitrosamine‐induced Liver Tumors in Mice and Chemoprevention by Leuprorelin
2001
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
2006 StandoutNature
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
2005 Standout
Structural Basis of the Drug-binding Specificity of Human Serum Albumin
2005 Standout
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Central nervous system injury-induced immune deficiency syndrome
2005 Standout
Early IL-6 Plasma Concentrations Correlate with Severity of Brain Injury and Pneumonia in Brain-Injured Patients
2002
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
2002
Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology
2000
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Hepatocellular carcinoma
2012 Standout
Serum YKL-40 is increased in patients with hepatic fibrosis
2000
Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients
2004
Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C
2001
Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non‐alcoholic fatty liver disease
2005
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Role of liver biopsy in management of chronic hepatitis C: A systematic review
2002
Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection
2009
Drug Binding in Plasma
1994
The NAFLD fibrosis score
2007 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Prevalence of Hypogonadism among Men with Weight Loss Related to Human Immunodeficiency Virus Infection Who Were Receiving Highly Active Antiretroviral Therapy
2000
Non-alcoholic fatty liver disease
2021 Standout
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: Role of IRS phosphorylation
2005
Fibrosis and disease progression in hepatitis C
2002
Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores
1998
Sex hormone receptors in hepatocellular carcinoma
1993
Sarcoidosis
1997 Standout
A G Protein-coupled Receptor Responsive to Bile Acids
2003
Primary Biliary Cirrhosis
1996
FIB-4
2007 Standout
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Advances in functional and molecular MRI technologies in chronic liver diseases
2020
Lipid signalling couples translational surveillance to systemic detoxification in Caenorhabditis elegans
2015 StandoutNobel
Importance of age in chronic hepatitis C virus infection
1997
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
A Double-blind, Placebo-Controlled Trial of Testosterone Therapy for HIV-Positive Men With Hypogonadal Symptoms
2000
Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial.
1998
Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis
2006
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease
2005
Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C
2003
Gut microbiota in human metabolic health and disease
2020 Standout
Fibrosis and disease progression in hepatitis C
2002
Evaluation of Liver Fibrosis: A Concise Review
2004
The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
2009
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
Primary Biliary Cirrhosis
2011 Standout
Hepatitis C virus NS5A protein interacts with 2′,5′-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner
2004
Antiviral Actions of Interferons
2001 Standout
Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: A randomized, controlled trial
1995
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Cellular Mechanisms of Tissue Fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis
2012
Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection.
2005
Role of liver biopsy in management of chronic hepatitis C: A systematic review
2002
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway
1999
Interactions between bile salts, gut microbiota, and hepatic innate immunity
2017
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Sex hormone receptors in hepatocellular carcinoma (HCC). Is there a rationale for hormonal treatment?
1991
Randomized Trial of Leuprorelin and Flutamide in Male Patients With Hepatocellular Carcinoma Treated With Tamoxifen
2004
Nonalcoholic Fatty Liver Disease
2015 Standout
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat
1999
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Works of Jérôme Guechot being referenced
Predictive factors in ursodeoxycholic acid-treated patients with primary biliary Cirrhosis: Role of serum markers of connective tissue†
1994
Changes in systemic gonadal and adrenal steroids in asymptomatic human immunodeficiency virus-infected men: relationship with the CD4 cell counts
1995
Evidence for a deficiency of interferon response in mononuclear cells from hepatitis C viremic patients
1997
Direct and indirect evidence for the reversibility of cirrhosis
2006
Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of α-interferon therapy
1995
CYTOKINE RESPONSE TO BURN INJURY
1994
Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C
1994
Differential Effects of Chenodeoxycholic and Ursodeoxycholic Acids on Interleukin 1, Interleukin 6 and Tumor Necrosis Factor-α Production by Monocytes
1992
An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: The Liver-FibroSTARD standards
2014
Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis
2000
Effect of d-tryptophan-6-luteinizing hormone-releasing hormone on the tumoral growth and plasma sex steroid levels in cirrhotic patients with hepatocellular carcinoma
1989
Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C
2007
Hepatic uptake of sex steroids in men with alcoholic cirrhosis
1987